Are heart attack patients without SMuRF risk profiles less likely to get recommended medications at discharge?
What the Evidence Shows
What we've found so far is that heart attack patients who do not have a specific risk profile — referred to as the SMuRF profile — appear to be less likely to receive the recommended medications when they leave the hospital. Our analysis of the available research suggests this may be linked to a higher chance of death after discharge.
We reviewed 42.0 studies or assertions that support this idea, and none that refute it . These findings indicate that patients without the SMuRF risk factors — which include things like high blood pressure, diabetes, smoking, and high cholesterol — are less often prescribed standard heart-protecting drugs at discharge. These medications typically include statins for cholesterol, drugs to lower blood pressure, and blood thinners like aspirin or anticoagulants. Even though these patients may seem healthier on paper, they still face serious risks after a heart attack, and skipping these medications might worsen their outcomes.
Our current analysis shows the evidence leans toward a pattern: not having the expected risk factors may lead doctors to underestimate the need for preventive treatment. This could leave some patients without the full protection these medications offer, potentially increasing their risk of complications or death later on.
However, we want to be clear — this is what we’ve found so far, based on the evidence we’ve reviewed. We don’t yet know all the reasons behind this treatment gap, and more research may help clarify whether these prescribing patterns are justified in some cases or represent a missed opportunity in care.
Practical takeaway: If you’ve had a heart attack, don’t assume you’re “healthy enough” to skip heart meds — talk to your doctor about whether you should still be on cholesterol drugs, blood pressure meds, or blood thinners, even if you don’t have traditional risk factors.